tiprankstipranks
Trending News
More News >
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market

Atossa Therapeutics (ATOS) Technical Analysis

Compare
2,316 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Atossa Therapeutics’s (ATOS) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Atossa Therapeutics is a Sell.
Atossa Therapeutics’s (ATOS) 20-Day exponential moving average is 0.68, while Atossa Therapeutics’s (ATOS) share price is $0.76, making it a Buy.
Atossa Therapeutics’s (ATOS) 50-Day exponential moving average is 0.73, while Atossa Therapeutics’s (ATOS) share price is $0.76, making it a Buy.

Atossa Therapeutics (ATOS) Pivot Points

Apr 26, 2025, 10:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.66
0.69
0.71
0.73
0.75
0.78
0.80
Fibonacci
0.69
0.70
0.72
0.73
0.75
0.76
0.78
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atossa Therapeutics (ATOS) Moving Averages

Apr 26, 2025, 10:15 AM
Period
Simple
Exponential
MA5
0.71Buy
0.71Buy
MA10
0.66Buy
0.68Buy
MA20
0.65Buy
0.68Buy
MA50
0.71Buy
0.73Buy
MA100
0.85Sell
0.85Sell
MA200
1.11Sell
1.05Sell
Atossa Therapeutics’s (ATOS) 10-Day exponential moving average is 0.68, while Atossa Therapeutics’s (ATOS) share price is $0.76, making it a Buy.
Atossa Therapeutics’s (ATOS) 100-Day exponential moving average is 0.85, while Atossa Therapeutics’s (ATOS) share price is $0.76, making it a Sell.
Atossa Therapeutics’s (ATOS) stock price is $0.76 and Atossa Therapeutics’s (ATOS) 50-day simple moving average is 0.71, creating a Buy signal.
Atossa Therapeutics’s (ATOS) stock price is $0.76 and Atossa Therapeutics’s (ATOS) 100-day simple moving average is 0.85, creating a Sell signal.
Atossa Therapeutics’s (ATOS) stock price is $0.76 and Atossa Therapeutics’s (ATOS) 200-day simple moving average is 1.11, creating a Sell signal.

Atossa Therapeutics (ATOS) Technical Indicators

Apr 26, 2025, 10:15 AM
Name
Value
Implied Action
RSI (14)
60.48
Neutral
STOCH (9,6)
88.29
Sell
STOCHRSI (14)
90.05
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
32.00
Neutral
Williams %R
-4.15
Sell
CCI (14)
178.34
Sell
ATR (14)
0.05
-
Ultimate Oscillator
58.44
Neutral
ROC
26.67
Buy
Atossa Therapeutics’s (ATOS) Relative Strength Index (RSI) is 60.48, creating a Neutral signal.
Atossa Therapeutics’s (ATOS) Trend Strength Indicator (ADX) is 32.00, creating a Neutral signal.
Atossa Therapeutics’s (ATOS) Commodity Channel Index (CCI) is 178.34, creating a Sell signal.
Atossa Therapeutics’s (ATOS) Price Rate of Change (ROC) is 26.67, creating a Buy signal.

FAQ

Is ATOS a Buy, Hold, or Sell?
Based on ATOS’s technical indicators, ATOS is a Hold.
    What is ATOS’s RSI (14)?
    ATOS’s RSI (14) is 60.48, which suggests ATOS is a Neutral.
      What is ATOS’s MACD?
      ATOS’s MACD is >-0.01, which suggests ATOS is a Sell.
        What is ATOS’s 5-day moving average?
        ATOS’s 5-day moving average is 0.71, which suggests ATOS is a Buy.
          What is ATOS’s 20-day moving average?
          ATOS 20-day moving average is 0.65, which suggests ATOS is a Buy.
            What is ATOS’s 50-day moving average?
            ATOS’s 50-day moving average is 0.71, which suggests ATOS is a Buy.
              What is ATOS’s 200-day moving average?
              ATOS’s 200-day moving average is 1.11, which suggests ATOS is a Sell.
                What is ATOS’s Williams % R (14)?
                ATOS’s Williams % R (14) is -4.15, which suggests ATOS is a Sell.
                  What is ATOS’s CCI (14)?
                  ATOS’s CCI (14) is 178.34, which suggests ATOS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis